Fig. 1From: Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma: a case reportChange in (a) plasma concentration of total (sunitinib + N-desethyl sunitinib), sunitinib and N-desethyl sunitinib, (b) platelet count, and (c) white blood cell count in the patient after starting sunitinib therapyBack to article page